Canopy Growth Corp (CGC)
$8.20
0.00 (0.00%)
CGC Stock Quote Delayed 30 Minutes
Tilray Prepares a Second Act That Could Rekindle TLRY Stock
Tilray stock has conspicuously taken a beating relative to the major cannabis players, but the underlying company's presence in the U.K. could change the narrative.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
4.81B
PE Ratio
-117.14
EPS
-0.07
Volume (Avg. Vol.)
8,267
Day's Range
-
52-Week Range
$2.76 - $19.20
Dividend & Yield
N/A (N/A)
CGC Stock Predictions, Articles, and Canopy Growth Corp News
Expect More Dips, Less Rips in Canopy Growth Stock
Canopy Growth (CGC) is poised to dominate the American cannabis market. But after a weak earnings report, its current sky-high valuation is in question.
Stick by CGC Stock Amidst the Volatility
CGC stock still leads the space in terms of breadth of vision for CBD applications, so stick by Canopy Growth stock.
Canopy Growth Stock Could Drop to $30
Here is something that Canopy Growth Corp investors should be concerned about after CGC stock's latest earnings report.
Monday’s Vital Data: Canopy Growth Corp, Microsoft and Netflix
Options trading was buzzing in Canopy Growth, Microsoft and Netflix. Here are the metrics that matter moving forward.
3 Big Stock Charts for Monday: Medtronic, Paychex and AbbVie
The stock charts of Medtronic, Paychex and AbbVie are poised to get the new trading week started with a bang.
Buy the Dip on Canopy Growth Stock Following Mixed Q4 Results
In terms of the breakdown between recreational and medical pot sales, recreational accounted for C$68.9 million (before excise taxes) in sales in the fourth quarter, down from C$71.6 million in the third quarter.
3 Big Stock Charts for Friday: Verizon, General Electric and Ventas
The stock charts of Verizon, General Electric and Ventas are ready to end the trading week at key pivot points.
The Short-Term Earnings Numbers for CGC Stock Aren’t Most Important
Shares of CGC stock will move after its earnings report, but what really matters is the long-term growth narrative for Canopy.
The Blue Chip of Pot: Can CGC Stock Rally 20% on Acreage Deal and Earnings?
CGC stock will report earnings on June 20th, just a day after it got the OK from shareholders for its $3.4 billion deal for Acreage Holdings.
Canopy Growth Stock Has One Massive Lever: Job Growth
Full legalization in the U.S. has always been the big potential of CGC stock, and recent geopolitical events suggest that this once pipe-dream may become a reality.
Diversification Is What Makes Aurora Stock a Solid Marijuana Play
ACB stock is still a very speculative name, but Aurora Cannabis' management has proven to be wise, and savvy.
Earnings Will Be Huge for Canopy Growth and Marijuana Stocks
The CGC stock price looks wobbly, as do most marijuana stocks. Good news from Canopy Growth in its earnings report could give both a boost.
America’s 2020 Election Is a Win-Win for Canopy Growth Stock
CGC stock investors may think they need a Democrat to win the 2020 election. However, the identity of the Democratic nominee may be much more important for Canopy.
CGC Stock Continues Week of Losses for Pot Stocks
Thursday’s 2.29% slide in CGC stock price reflects uncertainty about Canopy Growth’s forthcoming Q4 2019 results, cannabis market volatility.
This Is Why a REIT Could Be Great for Canopy Growth Stock
There could be a Canopy Growth REIT coming to a portfolio near you sooner than later. That could be wonderful news for CGC stock investors for the long haul.
CBD Products May Offer the Competitive Edge to Move Kroger Stock Higher
Recent reports say that Kroger will start selling CBD products at almost 1,000 of its stores. Will it be enough to boost Kroger stock?
Remember the Epic $100 December Rally in Netflix Stock? It’s Coming Back
All of 2019 NFLX is consolidating around a pivot. The end result of the stalemate will be a $100 move. The sequel to the December rally.
3 Things to Scrutinize in Canopy Growth’s Earnings Report
If you own CGC stock, next week's earnings report could be a doozie. Here are the things that could make or break Canopy stock.
